Cargando…
Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
BACKGROUND: Increased number of single nucleotide substitutions is seen in breast and ovarian cancer genomes carrying disease-associated mutations in BRCA1 or BRCA2. The significance of these genome-wide mutations is unknown. We hypothesize genome-wide mutation burden mirrors deficiencies in DNA rep...
Autores principales: | Birkbak, Nicolai Juul, Kochupurakkal, Bose, Izarzugaza, Jose M. G., Eklund, Aron C., Li, Yang, Liu, Joyce, Szallasi, Zoltan, Matulonis, Ursula A., Richardson, Andrea L., Iglehart, J. Dirk, Wang, Zhigang C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827141/ https://www.ncbi.nlm.nih.gov/pubmed/24265793 http://dx.doi.org/10.1371/journal.pone.0080023 |
Ejemplares similares
-
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
por: Przybytkowski, Ewa, et al.
Publicado: (2020) -
Jetset: selecting the optimal microarray probe set to represent a gene
por: Li, Qiyuan, et al.
Publicado: (2011) -
Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020) -
Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022) -
The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)